Neuropathy Target Esterase Is Required for Adult Vertebrate Axon Maintenance
暂无分享,去创建一个
P. Glynn | M. Chao | J. Cavanagh | D. Read | Yong Li
[1] Christos Proukakis,et al. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms , 2008, The Lancet Neurology.
[2] E. Koo,et al. Amyloid Precursor Protein Trafficking, Processing, and Function* , 2008, Journal of Biological Chemistry.
[3] Yi-Jun Wu,et al. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens. , 2008, Toxicology.
[4] J. Luzio,et al. Spastin Couples Microtubule Severing to Membrane Traffic in Completion of Cytokinesis and Secretion , 2008, Traffic.
[5] C. Blackstone,et al. Atlastin GTPases are required for Golgi apparatus and ER morphogenesis. , 2008, Human molecular genetics.
[6] H. Coon,et al. Neuropathy target esterase gene mutations cause motor neuron disease. , 2008, American journal of human genetics.
[7] S. Sakoda,et al. Neuroaxonal Dystrophy Caused by Group VIA Phospholipase A2 Deficiency in Mice: A Model of Human Neurodegenerative Disease , 2008, The Journal of Neuroscience.
[8] V. Bankaitis,et al. The Sec14-superfamily and the regulatory interface between phospholipid metabolism and membrane trafficking. , 2007, Biochimica et biophysica acta.
[9] J. Hauw,et al. A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. , 2006, Human molecular genetics.
[10] J. Luzio,et al. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. , 2006, Human molecular genetics.
[11] P. Glynn,et al. Loss of Swiss Cheese/Neuropathy Target Esterase Activity Causes Disruption of Phosphatidylcholine Homeostasis and Neuronal and Glial Death in Adult Drosophila , 2005, The Journal of Neuroscience.
[12] M. Esiri,et al. The extent of axonal loss in the long tracts in hereditary spastic paraplegia , 2004, Neuropathology and applied neurobiology.
[13] H. Kato,et al. An improved method for assaying phosphatidylcholine in mouse tissue. , 2004, Journal of pharmacological and toxicological methods.
[14] P. Glynn,et al. Neuropathy Target Esterase and Its Yeast Homologue Degrade Phosphatidylcholine to Glycerophosphocholine in Living Cells* , 2004, Journal of Biological Chemistry.
[15] K. Akassoglou,et al. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Glynn,et al. Placental Failure and Impaired Vasculogenesis Result in Embryonic Lethality for Neuropathy Target Esterase-Deficient Mice , 2004, Molecular and Cellular Biology.
[17] P. Glynn,et al. Protein Domains, Catalytic Activity, and Subcellular Distribution of Neuropathy Target Esterase in Mammalian Cells* , 2003, The Journal of Biological Chemistry.
[18] E. Reid,et al. Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias , 2003, Journal of medical genetics.
[19] P. Glynn. Neural development and neurodegeneration: two faces of Neuropathy Target Esterase , 2000, Progress in Neurobiology.
[20] A. Guidotti,et al. Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] P. Glynn,et al. Neuropathy target esterase: Immunolocalization to neuronal cell bodies and axons , 1998, Neuroscience.
[22] S. E. Patton,et al. Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate. , 1985, Toxicology and applied pharmacology.
[23] M. Lotti,et al. Repeated small doses of a neurotoxic organophosphate , 1980, Archives of Toxicology.
[24] M. Johnson,et al. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. , 1969, The Biochemical journal.
[25] C. Blackstone,et al. Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. , 2006, Pharmacology & therapeutics.
[26] T. Eagleton,et al. The Significance Of Theory , 1990 .
[27] J. Cavanagh. The significance of the "dying back" process in experimental and human neurological disease. , 1964, International review of experimental pathology.